Stockreport

Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock

Cognition Therapeutics, Inc.  (CGTX) 
PDF PURCHASE, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical stage company developin [Read more]